Notice2024-05777
Notice of Award of a Sole Source Cooperative Agreement To Fund National Health Laboratory Service (NHLS)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 19, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award(s) of approximately $5,000,000, for Year 1 funding to NHLS. The(se) award(s) will strengthen laboratory systems for improved access to sustainable delivery of quality laboratory services and promote rational use of diagnostic services in South Africa through above site interventions. Funding amounts for years 2-5 will be set at continuation.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 54 (Tuesday, March 19, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 54 (Tuesday, March 19, 2024)]
[Notices]
[Page 19594]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-05777]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Sole Source Cooperative Agreement To Fund
National Health Laboratory Service (NHLS)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
award(s) of approximately $5,000,000, for Year 1 funding to NHLS.
The(se) award(s) will strengthen laboratory systems for improved access
to sustainable delivery of quality laboratory services and promote
rational use of diagnostic services in South Africa through above site
interventions. Funding amounts for years 2-5 will be set at
continuation.
DATES: The period for this award will be September 30, 2024, through
September 29, 2029.
FOR FURTHER INFORMATION CONTACT: Artur Ramos, Center for Global Health,
Centers for Disease Control and Prevention, 100 Totius Street,
Groenkloof, Pretoria, telephone: 3108483712, e-Mail: <a href="/cdn-cgi/l/email-protection#1f7c7a6d265f7c7b7c31787069"><span class="__cf_email__" data-cfemail="1a797f68235a797e79347d756c">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The(se) sole source award(s) will address
gaps in line with PEPFAR strategies and the Government of South
Africa's key priority areas that need continued PEPFAR support. This
includes developing and reviewing laboratory policies, strategic plans,
and governance structures to expand diagnostic health equity and
response to Human Immunodeficiency Virus (HIV), Tuberculosis (TB) and
related public health needs. It also includes prioritizing technical
and systems advancements to increase operational efficiencies and
improve service delivery as well as supporting an environment that
facilitates and endorses integration, ownership, and sustainable
transition of PEPFAR-funded laboratory activities to NHLS and the
National Department of Health.
NHLS is in a unique position to conduct this work, as it is the
sole provider of diagnostic pathology services to the public sector in
South Africa and has been mandated by the government of South Africa
under the National Health Laboratory Service Act, 2000 to provide
quality, affordable, and sustainable laboratory and related public
health services. Quality laboratory testing is an essential building
block of the HIV clinical cascade as accurate and timely clinical
laboratory services will facilitate the earlier diagnosis of HIV,
staging, identification of adverse drug events and opportunistic
infections, and monitoring the response of individual patients to
therapy, including identification of treatment failures.
Summary of the Award
Recipient: National Health Laboratory Service (NHLS).
Purpose of the Award: The purpose of this award is to strengthen
laboratory systems for improved access to sustainable delivery of
quality laboratory services and promote rational use of diagnostic
services in South Africa through above site interventions.
Amount of Award: For NHLS, the approximate year 1 funding amount
will be $5,000,000 in Federal Fiscal Year (FYY) 2024 funds, subject to
the availability of funds. Funding amounts for years 2-5 will be set at
continuation.
Authority: This program is authorized under Public Law 108-25 (the
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act
of 2003) (22 U.S.C. 7601, et seq.) and Public Law 110-293 (the Tom
Lantos and Henry J. Hyde United States Global Leadership Against HIV/
AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008), and
Public Law 113-56 (PEPFAR Stewardship and Oversight Act of 2013).
Additionally, this program is authorized under section 307 of the
Public Health Service Act (42 U.S.C. 242l), as amended and section
301(a) of the Public Health Service Act (42 U.S.C. 241(a)), as amended.
Period of Performance: The period for this award will be September
30, 2024, through September 29, 2029.
Dated: March 13, 2024.
Jamie Legier
Acting Director, Office of Grants Services, Centers for Disease Control
and Prevention.
[FR Doc. 2024-05777 Filed 3-18-24; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 19, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.